Glycoside Etherification in Tetrahydropyran for High Purity

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for producing glycoside compounds result in impurities, leading to unsatisfactory purity levels.

Innovation Solution

A method involving the reaction of a glycoside compound with an ether compound in solvents like tetrahydropyran and 4-methyltetrahydropyran, in the presence of halogenating agents such as iodine, to suppress impurity formation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If a glycoside compound is reacted with a thioether compound in tetrahydrofuran as a solvent, then the glycoside compound can be produced, but the purity of the glycoside compound is not satisfactory due to impurity formation

Engineering Contradiction:
Improvepurity of glycoside compoundVSAvoidimpurity formation
Core Design Contradiction:
Manufacturing precisionVSObject-generated harmful factors

Solution Approach 1:

The invention changes the solvent parameter from tetrahydrofuran to tetrahydropyran or 4-methyltetrahydropyran, and changes the halogenating agent parameter to specific compounds (N-iodosuccinimide, iodine, or bromine), which resolves the impurity formation issue while maintaining the ether introduction reaction efficiency

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention converts the potentially harmful side reactions that occur in tetrahydrofuran into beneficial selective reactions by using specific halogenating agents (N-iodosuccinimide, iodine, or bromine) that promote the desired ether formation while minimizing impurity generation

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

2Productivity

If existing methods are used to produce glycoside compounds, then production can proceed, but impurities are formed leading to unsatisfactory purity levels

Engineering Contradiction:
Improveproduction efficiencyVSAvoidpurity of glycoside compound
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The invention optimizes reaction parameters by selecting specific solvents (tetrahydropyran, 4-methyltetrahydropyran) and halogenating agents (N-iodosuccinimide, iodine, bromine) that simultaneously maintain high reaction efficiency and produce high purity products, resolving the contradiction between productivity and manufacturing precision

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method achieves high purity glycoside compounds suitable for oligonucleic acid synthesis by minimizing impurities.

Implementation Method 1

reacting a glycoside compound represented by formula (1) with an ether compound represented by formula (2) in one or more solvents selected from tetrahydropyran and 4-methyltetrahydropyran in the presence of one or more halogenating agents selected from halogen, N-halogenated succinimide, and N-halogenated hydantoin

Methodology Applied
Scientific EffectHalogenation reaction: Chemical Bonding

Data Source

PatentUS12559512B2Method for producing glycoside compound
Publication Date: 2026.02.24 SUMITOMO CHEM CO LTD
  • US12559512B2 patent drawing
  • US12559512B2 patent drawing
  • US12559512B2 patent drawing

AI summary

A purpose of the present invention is to provide a method for producing a glycoside compound having a high purity. The present invention provides a method for producing a glycoside compound represented by formula (3) (wherein Ba, i-Pr and n are the same as those defined below), which comprises reacting a glycoside compound of formula (1) (wherein Ba represents an adenine group which may be optionally substituted with an acyl group, and i-Pr represents an isopropyl group) with an ether compound of formula (2) (wherein R1 represents a C1-C6 alkyl group or a phenyl group, and n is 0 or 1) in one or more solvents selected from tetrahydropyran and 4-methyltetrahydropyran in the presence of one or more halogenated agents selected from halogen, N-halogenated succinimide, and N-halogenated hydantoin.